| CPC A61K 38/162 (2013.01) [A61K 38/08 (2013.01); A61K 45/06 (2013.01); A61K 47/60 (2017.08); C07K 7/06 (2013.01); C12N 7/00 (2013.01); C12N 2740/16032 (2013.01); Y02A 50/30 (2018.01)] | 5 Claims |
|
1. A pharmaceutical composition for treating a gram positive or gram negative bacterial infection, comprising: (1) an antimicrobial peptide comprising an antimicrobial domain comprising the amino acid sequence of SEQ ID NO: 3 bound at the N- or C-terminus to a cell penetrating peptide (CPP) domain; and (2) a pharmaceutically acceptable carrier; wherein the CPP is one selected from the group consisting of HIV TAT49-.s7 peptide, HIV TAT 48-60 peptide, low molecular weight protamine (LMWP) peptide; Pep-1; Antp43-58 peptide, MPG (HIV Gp41-SV40 NLS), SAP, MPG R9, MAP, K-FGF, Penetratin, Buforin II, Transportan, Ku70, Prion, pVEC, Pep-1-K, Pep-7, HN-1, TP10, and CP26.
|